Loading clinical trials...
Loading clinical trials...
A Prospective, Parallel Group, Phase IV Study of Three Levels of MS LifeLines ® Support Services Provided to Patients Prescribed Rebif ® for Newly Diagnosed or First-switch Relapsing Remitting Multiple Sclerosis (RRMS)
Conditions
Interventions
Standard Services of Group A (Group A1)
Customized Services of Group A (Group A2)
+1 more
Locations
1
United States
Call EMD Serono Medical Information for information on recruiting sites
Boston, Massachusetts, United States
Start Date
July 1, 2013
Primary Completion Date
January 1, 2015
Completion Date
January 1, 2015
Last Updated
February 2, 2015
NCT06276634
NCT07225504
NCT06809192
NCT05359653
NCT07426991
NCT07376772
Lead Sponsor
EMD Serono
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions